Production (Stage)
Sensei Biotherapeutics, Inc.
SNSE
$0.3056
$0.01063.59%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -16.94% | -12.06% | -10.11% | -9.97% | -11.67% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 92.19% | -53.35% | -32.85% | -19.69% | 61.30% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 266.67% | 48.15% | -42.96% | -47.21% | -17.23% |
| Total Current Assets | -14.90% | -12.83% | -10.84% | -10.44% | -10.43% |
|
|
|||||
| Total Current Assets | -14.90% | -12.83% | -10.84% | -10.44% | -10.43% |
| Net Property, Plant & Equipment | -24.14% | -33.24% | -12.12% | -9.52% | -9.42% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -50.00% | -44.83% | 0.00% | 1.16% | 0.00% |
| Total Assets | -15.63% | -14.82% | -10.94% | -10.34% | -10.32% |
|
|
|||||
| Total Accounts Payable | 47.95% | -85.44% | 1.82% | -17.70% | 249.04% |
| Total Accrued Expenses | -3.66% | 105.03% | 56.96% | 64.98% | -78.67% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -7.20% | -4.77% | -0.86% | -0.93% | 1.60% |
| Total Finance Division Other Current Liabilities | -43.95% | -- | -- | -- | -- |
| Total Other Current Liabilities | -43.95% | -- | -- | -- | -- |
| Total Current Liabilities | -4.02% | 0.13% | 9.94% | -0.86% | -11.54% |
|
|
|||||
| Total Current Liabilities | -4.02% | 0.13% | 9.94% | -0.86% | -11.54% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -30.78% | -24.93% | -21.50% | -18.03% | -16.13% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -1.47% | 1.49% |
| Total Liabilities | -9.88% | -6.69% | -1.74% | -7.47% | -13.27% |
|
|
|||||
| Common Stock & APIC | 0.15% | 0.13% | 0.24% | 0.27% | 0.50% |
| Retained Earnings | -2.62% | -3.06% | -2.94% | -2.98% | -3.45% |
| Treasury Stock & Other | 53.85% | -192.86% | 115.05% | 32.12% | 34.45% |
| Total Common Equity | -16.67% | -16.15% | -12.29% | -10.74% | -9.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.67% | -16.15% | -12.29% | -10.74% | -9.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.67% | -16.15% | -12.29% | -10.74% | -9.89% |
|
|
|||||